How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) released its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analyst estimates of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. The firm's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.23) earnings per share.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com . Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD) , AbbVie (ABBV) , Advanced Micro Devices (AMD) , Medtronic (MDT) , Pfizer (PFE) , ACADIA Pharmaceuticals (ACAD) , Johnson & Johnson (JNJ) , Merck & Co., Inc. (MRK) and Procter & Gamble (PG) .

NASDAQ:CSII

Cardiovascular Systems (CSII) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

Free CSII Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $20.00
▼
$20.00
50-Day Range: $19.87
▼
$20.00
52-Week Range: $12.26
▼
$20.57

Volume: 4,300 shs
Average Volume: 765,906 shs
Market Capitalization: $843.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Cardiovascular Systems alerts:

Cardiovascular Systems MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: N/A
Dividend Strength: N/A
Sustainability: -1.05
Upright™ Environmental Score
News Sentiment: -0.11
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.68) to ($0.51) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.27 out of 5 stars

Medical Sector

905th out of 929 stocks

Surgical & Medical Instruments Industry

96th out of 97 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cardiovascular Systems.

N/A

Short Interest

Short Interest
There is no current short interest data available for CSII.

0.0

Dividend Strength

Dividend Yield
Cardiovascular Systems does not currently pay a dividend.
Dividend Growth
Cardiovascular Systems does not have a long track record of dividend growth.

4.2

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Cardiovascular Systems has received a 61.33% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Clinical research services for physiological diseases ", "Coronary stents", and "Catheters" products. See details.
Environmental Sustainability
The Environmental Impact score for Cardiovascular Systems is -1.05.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 3 news articles for Cardiovascular Systems this week, compared to 0 articles on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cardiovascular Systems insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.80% of the stock of Cardiovascular Systems is held by insiders.
Percentage Held by Institutions
86.61% of the stock of Cardiovascular Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Cardiovascular Systems are expected to grow in the coming year, from ($0.68) to ($0.51) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Cardiovascular Systems is -20.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Cardiovascular Systems has a P/B Ratio of 3.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.

Click here to see Louis' new video for yourself.

About Cardiovascular Systems Stock (NASDAQ:CSII)

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.

Click here to see Louis' new video for yourself.

CSII Stock News Headlines

April 13, 2024 | msn.com

Patient-centered cardiovascular care enhances outcomes

April 11, 2024 | msn.com

Cardiovascular care centered on the patient is key and helps improve equity and outcomes, say experts

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

April 9, 2024 | msn.com

A Transformational Advance in Medicine: Meridian Cardiovascular Systems Redefines the Treatment of Cardiovascular Disease and Beyond

April 3, 2024 | msn.com

New research links social factors to cardiovascular risk in Asian American adults

March 25, 2024 | msn.com

Sulpizio Cardiovascular Center Installs Advanced Pacemaker

March 14, 2024 | msn.com

Cardiologists lead national study on novel bleeding monitoring system

March 14, 2024 | msn.com

Pilot program for virtual cardiac rehab expands to new hospitals

April 16, 2024 | InvestorPlace (Ad)

Nerd Investor Reveals Secret To Make Money With A.I.

He's doing something he's never done before. In ten years, this nerd investor has picked 210+ stocks that have gone up at least 100%.

March 6, 2024 | msn.com

Increased daily step count may reduce the risk of death and cardiovascular disease

March 6, 2024 | msn.com

A daily step count goal may counteract the effects of sitting all day, study finds

February 28, 2024 | msn.com

Menu calorie labeling may reduce deaths from cardiovascular disease in England, modeling study suggests

February 15, 2024 | tmcnet.com

PINC AI™ and Fortune Name the Nation's 50 Top Cardiovascular Hospitals™

February 12, 2024 | msn.com

A century of progress in the fight against cardiovascular disease

February 7, 2024 | msn.com

Heart-brain axis dysfunction: Sports-related concussions can alter cardiovascular function

February 7, 2024 | tmcnet.com

Cardiology Information Systems: Enhancing Cardiovascular Care and Driving Market Growth to US$ 3.4 Billion by 2034

January 22, 2024 | msn.com

New Research Shows How Resistance Training May Help Reduce Cardiovascular Disease Risk

January 22, 2024 | msn.com

Emergency cardiovascular care impact goal outlines three target needs

January 2, 2024 | msn.com

The 4 New Year's Resolutions Cardiologists Always Make

December 26, 2023 | msn.com

Did You Know That Cardio Uses 3 Different Energy Systems? Here’s How To Shape Your Workout To Maximize the Benefits of Each

December 14, 2023 | msn.com

Eating meals early could reduce cardiovascular risk

December 12, 2023 | markets.businessinsider.com

MyCardiologist Revolutionizes Heart Health Assessment & Cardiac Event Reduction with Cutting-Edge Cardiac PET Imaging

December 2, 2023 | msn.com

Cardiovascular diseases: Expert explains why they occur

September 23, 2023 | msn.com

Stress a key factor in cardiovascular disease, a top cause of mortality across SA

September 14, 2023 | msn.com

FDA approves CorVista’s medical device system for cardiac disease

July 22, 2023 | msn.com

Caviar: The Definitive Guide from Health Experts

July 12, 2023 | msn.com

Cleveland research among vets shows heart health risks tied to where they live

See More Headlines

Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2023
Today: 4/16/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Current Symbol: NASDAQ:CSII
CUSIP: 14161910
CIK: 1180145
Web: www.csi360.com
Phone: (651) 259-1600
Fax: 612-677-3355
Employees: 780
Year Founded: 1989

Profitability

EPS (Most Recent Fiscal Year): ($0.97)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-36,930,000.00
Net Margins: -15.79%
Pretax Margin: -15.73%
Return on Equity: -15.39%
Return on Assets: -11.93%

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 6.04
Quick Ratio: 4.92

Sales & Book Value

Annual Sales: $239.84 million
Price / Sales: 3.52
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.12 per share
Price / Book: 3.27

Miscellaneous

Outstanding Shares: 42,198,000
Free Float: 40,594,000
Market Cap: $843.96 million
Optionable: Optionable
Beta: 0.74

Social Links

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Scott R. Ward
Chairman, President & Chief Executive Officer
John M. Hastings
Executive Vice President-Operations & Technology
Jeffrey S. Points
Chief Financial Officer
Jeffery W. Chambers
Chief Medical Officer
Andrew P. O'Brien
Vice President-Information Technology

Key Competitors

View All Competitors

CSII Stock Analysis - Frequently Asked Questions

How were Cardiovascular Systems' earnings last quarter?: Cardiovascular Systems, Inc. (NASDAQ:CSII) released its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The medical device company earned $61.45 million during the quarter, compared to analyst estimates of $63.06 million. Cardiovascular Systems had a negative net margin of 15.79% and a negative trailing twelve-month return on equity of 15.39%. The firm's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.23) earnings per share.
What is Scott Ward's approval rating as Cardiovascular Systems' CEO?: 35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.
What other stocks do shareholders of Cardiovascular Systems own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

This page (NASDAQ:CSII) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cardiovascular Systems (CSII) Stock Price, News & Analysis

Cardiovascular Systems MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Coverage This Week

Company Ownership

Earnings and Valuation

About Cardiovascular Systems Stock (NASDAQ:CSII)

CSII Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

CSII Stock Analysis - Frequently Asked Questions

Overall MarketRank^™